Literature DB >> 1571117

Effect of wound infections on head and neck cancer.

H H Ramadan1, S J Wetmore.   

Abstract

There seems to be a consensus in the surgical literature that wound infections after surgery for cancer have a favorable effect on the course of certain malignant diseases. In a review of laryngeal cancer during a 10-year period, the recurrence rate was statistically lower in the group that suffered wound infections than in the group that did not have a wound infection.

Entities:  

Mesh：

Year:  1992        PMID： 1571117     DOI： 10.1001/archotol.1992.01880050032007

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN： 0886-4470


  5 in total

1.  [Oral squamous cell carcinoma Retrospective analysis of therapy results and prognosis by neoadjuvant, preoperative radio-chemotherapy].

Authors:  T Reuther; N K Posselt; J Rabbels; A C Kübler
Journal:  Mund Kiefer Gesichtschir       Date:  2006-01

2.  Prognostic significance of wound infections following major head and neck cancer surgery: an open non-comparative prospective study.

Authors:  Nicolas Penel; Charles Fournier; Micheline Roussel-Delvallez; Danièle Lefebvre; Ahmed Kara; Yann Mallet; Jean-Charles Neu; Jean-Louis Lefebvre
Journal:  Support Care Cancer       Date:  2004-09       Impact factor: 3.603

3.  Surgical site infection in clean-contaminated head and neck cancer surgery: risk factors and prognosis.

Authors:  Hitoshi Hirakawa; Yasuhisa Hasegawa; Nobuhiro Hanai; Taijiro Ozawa; Ikuo Hyodo; Mikio Suzuki
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-04       Impact factor: 2.503

4.  [Recurrent tumors in the oral and maxillofacial region. Results and treatment strategies in 20 years].

Authors:  A Eckardt; E Barth; S Janssen; G Wegener
Journal:  Mund Kiefer Gesichtschir       Date:  2004-04-02

5.  Postoperative wound complications and systemic recurrence in breast cancer.

Authors:  B L Murthy; C S Thomson; D Dodwell; H Shenoy; J S Mikeljevic; D Forman; K Horgan
Journal:  Br J Cancer       Date:  2007-10-30       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.